• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨侵蚀性疾病中的类黄酮:骨质疏松症治疗的新视角。

Flavonoids in Bone Erosive Diseases: Perspectives in Osteoporosis Treatment.

机构信息

IRCCS Istituto Ortopedico Rizzoli, SC Scienze e Tecnologie Chirurgiche - SS Piattaforma Scienze Omiche per Ortopedia Personalizzata, Bologna, Italy.

University of Palermo, Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), Section of Cellular Biology, Palermo, Italy.

出版信息

Trends Endocrinol Metab. 2021 Feb;32(2):76-94. doi: 10.1016/j.tem.2020.11.007. Epub 2020 Dec 4.

DOI:10.1016/j.tem.2020.11.007
PMID:33288387
Abstract

Imbalance of bone homeostasis, with excessive bone resorption compared with bone formation, leads to the development of progressive osteopenia leading to lower bone resistance to load, with consequent pain and functional limitations. Phytochemicals with therapeutic and preventive effects against bone resorption have recently received increasing attention since they are potentially more suitable for long-term use than traditional therapeutic chemical compounds. In this systematic review of the literature of the past 5 years, comprehensive information is provided on flavonoids with potential antiresorption and pro-osteogenic effects. It aims to highlight the molecular mechanisms of these molecules, often epigenetic, and their possible pharmacological use, which is of great importance for the prevention and treatment of osteoporosis (OP).

摘要

骨稳态失衡,破骨作用强于成骨作用,导致进行性骨质疏松症的发生,使骨对负荷的抵抗力降低,从而引起疼痛和功能受限。具有抗吸收作用的植物化学物质具有治疗和预防作用,最近受到越来越多的关注,因为它们比传统的治疗性化合物更适合长期使用。在对过去 5 年文献的系统综述中,提供了具有潜在抗吸收和促成骨作用的类黄酮的综合信息。其目的是强调这些分子的分子机制,通常是表观遗传机制,以及它们可能的药理学用途,这对于骨质疏松症(OP)的预防和治疗非常重要。

相似文献

1
Flavonoids in Bone Erosive Diseases: Perspectives in Osteoporosis Treatment.骨侵蚀性疾病中的类黄酮:骨质疏松症治疗的新视角。
Trends Endocrinol Metab. 2021 Feb;32(2):76-94. doi: 10.1016/j.tem.2020.11.007. Epub 2020 Dec 4.
2
Terpenoid treatment in osteoporosis: this is where we have come in research.萜类化合物在骨质疏松症治疗中的应用:这就是我们在该研究领域所取得的进展。
Trends Endocrinol Metab. 2021 Nov;32(11):846-861. doi: 10.1016/j.tem.2021.07.011. Epub 2021 Sep 1.
3
Non-flavonoid polyphenols in osteoporosis: preclinical evidence.骨质疏松症中非黄酮类多酚:临床前证据。
Trends Endocrinol Metab. 2021 Jul;32(7):515-529. doi: 10.1016/j.tem.2021.03.008. Epub 2021 Apr 21.
4
Osteoblast-n-Osteoclast: Making Headway to Osteoporosis Treatment.成骨细胞与破骨细胞:骨质疏松症治疗取得进展
Curr Drug Targets. 2020;21(16):1640-1651. doi: 10.2174/1389450121666200731173522.
5
Cxcl9l and Cxcr3.2 regulate recruitment of osteoclast progenitors to bone matrix in a medaka osteoporosis model.Cxcl9l 和 Cxcr3.2 调节日本鳗鲡骨质疏松模型中破骨细胞前体向骨基质的募集。
Proc Natl Acad Sci U S A. 2020 Aug 11;117(32):19276-19286. doi: 10.1073/pnas.2006093117. Epub 2020 Jul 27.
6
Preservation of type H vessels and osteoblasts by enhanced preosteoclast platelet-derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice.增强破骨前血小板衍生生长因子 BB 对 H 型血管和成骨细胞的保护作用可减轻生长小鼠糖皮质激素诱导的骨质疏松症。
Bone. 2018 Sep;114:1-13. doi: 10.1016/j.bone.2018.05.025. Epub 2018 May 23.
7
Natural products for treatment of bone erosive diseases: The effects and mechanisms on inhibiting osteoclastogenesis and bone resorption.用于治疗骨侵蚀性疾病的天然产物:抑制破骨细胞生成和骨吸收的作用及机制
Int Immunopharmacol. 2016 Jul;36:118-131. doi: 10.1016/j.intimp.2016.04.024. Epub 2016 Apr 29.
8
DDR2 (discoidin domain receptor 2) suppresses osteoclastogenesis and is a potential therapeutic target in osteoporosis.盘状结构域受体2(DDR2)可抑制破骨细胞生成,是骨质疏松症的一个潜在治疗靶点。
Sci Signal. 2015 Mar 24;8(369):ra31. doi: 10.1126/scisignal.2005835.
9
Therapeutic and Mechanistic Approaches of Flavonoids for the Treatment of Osteoporosis.黄酮类化合物治疗骨质疏松症的治疗方法和机制。
Curr Drug Targets. 2020;21(16):1687-1702. doi: 10.2174/1389450121666200719012116.
10
A Novel Rhein Derivative Modulates Bone Formation and Resorption and Ameliorates Estrogen-Dependent Bone Loss.一种新型瑞香素衍生物可调节骨形成和骨吸收,改善雌激素依赖性骨丢失。
J Bone Miner Res. 2019 Feb;34(2):361-374. doi: 10.1002/jbmr.3604. Epub 2018 Nov 5.

引用本文的文献

1
Advancements in research on the anti-aging effects and mechanisms of flavonoids in natural products.天然产物中黄酮类化合物抗衰老作用及机制的研究进展
Front Med (Lausanne). 2025 Aug 19;12:1637992. doi: 10.3389/fmed.2025.1637992. eCollection 2025.
2
Nanotechnology in Osteogenesis and Inflammation Management: Metal-Organic Frameworks, Metal Complexes, and Biomaterials for Bone Restoration.纳米技术在骨生成与炎症管理中的应用:用于骨修复的金属有机框架、金属配合物和生物材料
Biomedicines. 2025 Jun 30;13(7):1597. doi: 10.3390/biomedicines13071597.
3
Nrf2 signaling pathway: focus on oxidative stress in osteoporosis.
核因子E2相关因子2(Nrf2)信号通路:聚焦于骨质疏松症中的氧化应激
Osteoporos Int. 2025 Jul 15. doi: 10.1007/s00198-025-07592-0.
4
Flavonoids, Chalcones, and Their Fluorinated Derivatives-Recent Advances in Synthesis and Potential Medical Applications.类黄酮、查耳酮及其氟化衍生物——合成与潜在医学应用的最新进展
Molecules. 2025 May 30;30(11):2395. doi: 10.3390/molecules30112395.
5
Plant-Origin Compounds and Materials for Advancing Bone Tissue Engineering and 3D Bioprinting: Traditional Medicine Aspects and Current Perspectives.用于推进骨组织工程和3D生物打印的植物源化合物与材料:传统医学视角与当前观点
J Tissue Eng Regen Med. 2025 Jan 7;2025:2812191. doi: 10.1155/term/2812191. eCollection 2025.
6
Colla Carapacis et Plastri ameliorates postmenopausal osteoporosis and macrophage immunity by modulating the RANK/RANKL/OPG signaling pathway in ovariectomized rats.龟甲胶通过调节去卵巢大鼠的RANK/RANKL/OPG信号通路改善绝经后骨质疏松症和巨噬细胞免疫。
Korean J Physiol Pharmacol. 2025 Jul 1;29(4):443-454. doi: 10.4196/kjpp.24.248. Epub 2025 Apr 11.
7
Enhancing Akkermansia growth via phytohormones: a strategy to modulate the gut-bone axis in postmenopausal osteoporosis therapy.通过植物激素促进阿克曼氏菌生长:一种在绝经后骨质疏松症治疗中调节肠-骨轴的策略。
J Transl Med. 2025 Apr 9;23(1):410. doi: 10.1186/s12967-025-06426-1.
8
The Mechanism by Which Estrogen Level Affects Knee Osteoarthritis Pain in Perimenopause and Non-Pharmacological Measures.雌激素水平影响围绝经期膝关节骨关节炎疼痛的机制及非药物措施
Int J Mol Sci. 2025 Mar 7;26(6):2391. doi: 10.3390/ijms26062391.
9
Accelerating Bone Healing With METTL3 Overexpressed Adipose-Derived Stem Cells in Osteoporotic Rats.在骨质疏松大鼠中用METTL3过表达的脂肪来源干细胞加速骨愈合
Cell Prolif. 2025 Sep;58(9):e70029. doi: 10.1111/cpr.70029. Epub 2025 Mar 24.
10
Nrf2 Activation as a Therapeutic Target for Flavonoids in Aging-Related Osteoporosis.Nrf2激活作为黄酮类化合物在衰老相关骨质疏松症中的治疗靶点。
Nutrients. 2025 Jan 13;17(2):267. doi: 10.3390/nu17020267.